Bone morphogenetic protein-6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophages
Bone morphogenetic protein-6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophages
复制标题
DOI:
10.1111/cas.12206
复制
发表时间:
2013-08-01
期刊:
影响因子:
5.7
通讯作者:
Kim, Isaac Y.
中科院分区:
文献类型:
--
作者:
Lee, Geun Taek;Jung, Yeon Suk;Kim, Isaac Y.
Bone morphogenetic protein (BMP) is a pleiotropic growth factor that has been implicated in inflammation and prostate cancer (CaP) progression. We investigated the potential role of BMP-6 in the context of macrophages and castration-resistant prostate cancer. When the androgen-responsive murine ( P 8) and human (LNCaP) CaP cell lines were cocultured with macrophages in the presence of dihydrotestosterone, BMP-6 increased androgen-responsive promoter activity and cell count significantly. Subsequent studies revealed that BMP-6 increased the expression level of androgen receptor (AR) mRNA and protein in CaP cell lines only in the presence of macrophages. Simultaneously, the AR antagonists bicalutamide and MDV3100 partially or completely blocked BMP-6-induced macrophage-mediated androgen hypersensitivity in CaP cells. Abolishing interleukin-6 signaling with neutralizing antibody in CaP/macrophage cocultures inhibited the BMP-6-mediated AR upregulation in CaP cells. Using P 8 cells with a tetracycline-inducible expression of BMP-6, the induction of BMP-6 in vivo resulted in a significant resistance to castration. However, this resistance was blocked after the removal of macrophages with clodronate liposomes. BMP-6 induces castration resistance by increasing the expression of AR through macrophage-derived interleukin-6.